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a)
Figure 1
b)
Figure > aI and bI shows kinetics of 
adenoviremia after treatment with 
Cidofovir and Brincidofovir respectively5
Viral load 3log>9  copies=mlI are plotted on 
y-axis and days after HCT are plotted on 
x-axis5 Cidofovir mediated major virological 
responses 32 log reduction in 2 weeksI in 
2 of 23 episodes5 In contrastM >3 of >8 
episodes demonstrated major virological 
responses with Brincidofovir 3p<0.0001I5 
The majority of responses to Brincidofovir 
were major5 Minor responses 3> log 
reduction in 2 weeksI were observed only in two episodes5 Brincidofovir mediated complete 
responses in >3 patients 389TI and Cidofovir mediated complete responses in 8 patients 335TI 
3p<0.01I5 Figure > cI compares the lymphocyte count at the resolution of viremia following 
treatment with Brincidofovir 3n=>5I and Cidofovir 3n=8I5 The median lymphocyte count at the 
resoluton of viremia after Brincidofovir versus Cidofovir was 329=microlitre versus 9>9=microlitre 
respectively5 The resolution of viremia occurred in the Brincidofovir group despite signficant 
lymphopenia of > 399=microlitre5 In contrastM resolution of viremia occured in the Cidofovir group 
when lymphocyte count was > 399=microlitre 3p<0.05I
p<0.05
c)
Figure 2
(a)
Figure A a4 shows kinetics of adenoviremia Nplotted on 
left y-axis4 and corresponding lymphocyte count Nplotted 
on right y-axis4 in VA episodes treated with Cidofovir 
followed by Brincidofovir6 Days after HCT are plotted on 
x-axis6 Black arrows indicate start of Cidofovir and blue 
arrows indicate start of Brincidofovir6 Major Nshown as blue 
line4 and minor responses Nshown as interupted blue line4 
were observed in q of VV episodes unresponsive to Cidofovir6 
No response in A weeks is shown as red line6 The circulating 
lymphocyte count is shown as brown line and CD<3 T-cell 
count Nwhere available4 is shown as black diamond6 The 
median circulating lymphocyte count at complete 
response was 7,,Imicrolitre NV:, - 7,,,46 In patient 
number V,0 coexistent CMV viremia Nshown as interuppted black line4 resulted in T-cell expansion and 
resolution of CMV viremia6 However0 adenoviremia and gut adenoviral disease continued despite CD<3 T cell 
reconstitution6 Adenovirus-specific T-cell response was absent despite CD<3 T-cell expansion Nshown as 
black circle46 In the remaining 5 patients who had lymphocyte subsets measured0 CD<3 T-cells were < V,,I
microlitre6 Figure A b4 shows change in adenovirus load between Cidofovir and Brincidofovir in patients 
unresponsive to Cidofovir Nn=VV46 The median change in logV, viral load on Cidofovir treatment was 3V6A 
Nrange0 ,67 to A6746 In contrast0 median change in logV, viral load after A weeks of Brincidofovir treatment was 
-A6q NrangeP -=6V to ,6:8 p<,6,,=46 The solid lines represent median and interquartile range and whiskers 
represent minimum and maximum values6  
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